Skip to content
Screener

Bruker BRKR Accrued Expenses

Accrued Expenses at other companies

Danaher logo
DanaherDHR
$4.87B+6.7%
TEC
Bio-TechneTECH
$54.43M-12.1%
WAT
Waters CorporationWAT
$22M+83.3%
Agilent Technologies logo
Agilent TechnologiesA
$298M-20.3%
908 Devices logo
908 DevicesMASS
$4.67M-5.9%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$24.74M-5.2%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemJune 30,2026December 31,2025
Current portion of long-term debt and finance lease obligations$10.1$16.6
Accounts payable200.2215.9
Current portion of deferred revenue and customer advances444.6441.3
Other current liabilities549.8605.4
Total current liabilities1,204.71,279.2
Long-term debt1,814.71,852.5
Other long-term liabilities597.7599.4
Redeemable noncontrolling interests35.636.8

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's accrued expenses?
Bruker (BRKR) reported accrued expenses of $549.8M in Q2 2026.
How has Bruker's accrued expenses changed year-over-year?
Bruker's accrued expenses decreased by 3.6% year-over-year, from $570.6M to $549.8M.
What is the long-term trend for Bruker's accrued expenses?
Over 5 years (2020 to 2025), Bruker's accrued expenses has grown at a 5.4% compound annual growth rate (CAGR), from $465.9M to $605.4M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Bruker's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude